AdisInsight: Drugs (formerly Adis R&D Insight) provides leading, evidence-based scientific and market information on drugs in commercial development worldwide. Drug and cell-based products are tracked across all therapeutic areas and throughout the entire development process, from discovery to launch.
Data is collected from more than 2,300 biomedical journals covering drugs and therapeutics, news services, newsletters, company annual reports, contact with companies, market intelligence, meetings and conferences. AdisInsight profiles are also backed by more than 10,000 evaluated Adis scientific summaries and 63,000 bibliographic references.
Drug profiles in AdisInsight: Drugs include:
- Key development milestones
- Development status and history
- Drug properties
- Chemical synopses
- Generic name, syonyms, brand names
- Pharmacokinetics data
- Pharmacodynamics data
- Company agreements
- Trial landscape and details
- Related safety reports
- Patent information
- Related drugs
- Drug limitations
- Developing companies
- Forecasts of approval probability
- Use Chemical Engineering & Biotechnology Abstracts to answer questions like:
Use AdisInsight: Drugs to answer such questions as:
- What pipeline reports are available on nivolumab?
- Where is TSR 042 being developed? For which indications?
- Which drugs indicated for glioblastoma are in Phase III in France?
- Which drugs is Celgene developing?
- Which drugs indicated for acne are in highest phase I?
Gale Group Trade & Industry Database™ is a multi-industry database covering international company, industry, product, and market information, with strong coverage of areas such as management...
ABI/INFORM Professional is the world renowned multidisciplinary business research database from ProQuest. All content is indexed and maintained by a team of editorial business classification...
The IFI CLAIMS / US Patents and Legal Status database is produced by IFI CLAIMS® Patent Services. The database provides access to more than 6 million granted United States patents issued by the U.S....
LexisNexis Univentio Global Patents provides access to the complete text of patents issued by 33 countries and patenting authorities around the world, and the bibliographic data of 72 additional...
Celebrating its 55th anniversary in 2018, Derwent World Patents Index (DWPISM), produced by Clarivate Analytics, provides access to information for over 37.4 million inventions covering more than...
Derwent Patents Citation Index (DPCI), produced by Clarivate Analytics, provides access to more than 98 million patent and 11 million literature citations found in more than 11 million patent...